Alyssum Therapeutics

Cambridge, MA · Founded 2011 · Privately Held (backing)

Developer of supramolecular therapeutics designed for cancer patients. Alyssum Therapeutics is based in Cambridge, MA and was founded in 2011. Its last reported valuation was $13.3 million in Mar 2017. It has raised $32.7 million.

Last reported valuation
$13.3M
Oct 2026
Priced at
—
Total raised
$32.7M
Last round
—

Who backs Alyssum Therapeutics?

10 investors
InvestorType
AccelVenture capital
REMUS CapitalVenture capital
FemHealth VenturesVenture capital
Romulus Capital—
Aarin Capital—
Consilium Ventures—
Famy (India)—
Patrick Soon-Shiong—
Ratan Tata—
Sabre Partners—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Alyssum Therapeutics investors

10 investors are on record for Alyssum Therapeutics, including Accel, REMUS Capital, FemHealth Ventures and Romulus Capital.

Free account
More of Alyssum Therapeutics with a free account
  • ·Watch Alyssum Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 10 firms already write checks for companies like Alyssum Therapeutics. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View